🇺🇸 FDA
Company

Atrium

Atrium Therapeutics

RNA pharma USA

Quick answer

Atrium is a pharma company (RNA) headquartered in SAN DIEGO, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

PGET

Osteoarthritis

Phase 3 · other · terminated

1 trials project

Phlebotomy

Hemochromatosis

Phase 3 · other · completed

1 trials project

Phlebotomy and erythrocytapheresis

Hereditary Hemochromatosis

Phase 3 · other · active

1 trials project

Ropivacaine HCL

Renal Carcinoma

Phase 3 · small_molecule · active

1 trials project

Wobenzym® N

Knee Osteoarthritis

Phase 3 · other · terminated

1 trials project

eythrocytapheresis

Pre Operative Autologous Donation

Phase 3 · other · completed

1 trials project

Carboplatin

Lung Cancer Stage II

Phase 2 · small_molecule · active

1 trials project

Diclofenac

Wobenzym

Phase 2 · small_molecule · completed

1 trials project

Elotuzumab

Multiple Myeloma

Phase 2 · small_molecule · completed

1 trials project

Low-dose ASA

Germ Cell Tumor

Phase 2 · small_molecule · active

1 trials project

Metformin Hydrochloride ER

Sarcoma Metastatic

Phase 2 · small_molecule · active

1 trials project

Nivolumab

Multiple Myeloma

Phase 2 · small_molecule · active

1 trials project

Olutasidenib

IDH1 Mutation

Phase 2 · small_molecule · active

1 trials project

Vaccine

Pediatric Cancer

Phase 2 · mab · active

1 trials project

anastrozole

Female Breast Carcinoma

Phase 2 · small_molecule · active

1 trials project

IVAC MUTANOME, RBL001/RBL002

Melanoma

Phase 1 · mab · completed

1 trials project

Nivolumab

Brain and Nervous System

Phase 1 · small_molecule · completed

1 trials project

Novel Supplement Based Therapy

Small Intestinal Bacterial Overgrowth

Phase 1 · other · terminated

1 trials project

RBL001/RBL002

Melanoma

Phase 1 · mab · completed

1 trials project

SAR441000

Metastatic Neoplasm

Phase 1 · small_molecule · terminated

1 trials project

Phenoxybenzamine

Pheochromocytoma

Approved · small_molecule · completed

1 trials project

Rivastigmine

Parkinson's Disease

Approved · small_molecule · terminated

1 trials project

Abciximab local infusion

Acute Anterior Myocardial Infarction

Unknown · small_molecule · completed

1 trials project

Cranberry

Endotoxemia

Unknown · other · completed

1 trials

Patents (8)

patent

US 11793912

Cross-linked fatty acid-based biomaterials

Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11166929

Fatty-acid based particles

Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11097035

Compositions and methods for altering the rate of hydrolysis of cured oil-based

Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11083823

Tissue-separating fatty acid adhesion barrier

Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10888617

Cured oil-hydrogel biomaterial compositions for controlled drug delivery

Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10869902

Cured gel and method of making

Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10864304

Anti-infective antimicrobial-containing biomaterials

Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10814043

Cross-linked fatty acid-based biomaterials

Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)